Reckitt Benckiser India plans to buy around 26% stake in its sister firm Reckitt Benckiser Healthcare for Rs 725 crore.

Reckitt Benckiser India adds healthcare to its homecare portfolio with vigour and aggression, but the jury is still out on whether it made ...

"In all, some 10 executives are likely to join Reckitt from Hindustan Unilever in the short term," a person close to the developments said.

Emami, Marico and Wipro Consumer are in the final lap to acquire Paras Pharma's 100-crore personal care business from Reckitt Benckiser.

Reckitt Benckiser would absorb top 10 executives of Paras Pharmaceuticals and retain 200 people working at its Baddi plant in an in-princip...

Barely two days after he sold off Paras Pharmaceuticals, Girish Patel is back to what he does best—building enterprise.

Emami's unsuccessful attempt to acquire Paras Pharma may boost its short-term outlook, but the development will put pressure to identify ot...

A leading UK-based company is all set to buy Ahmedabad-based Paras Pharmaceuticals, a person close to the development said.

Darshan Patel, the estranged brother of Paras Pharmaceuticals CMD Girish Patel, is set to take on brands such as DermiCool, ItchGuard and B...

British giant GlaxoSmithKline, France's Sanofi-Aventis, Swiss multinational Novartis, and US-based Johnson and Johnson have all made bids f...

Taisho Pharmaceuticals has emerged as the front-runner to buy a majority stake in Paras Pharmaceuticals by offering over six times the annu...